GOLDEN, Colo.–(BUSINESS WIRE)–“We are pleased to receive this grant from the NIH to evaluate the feasibility of needle-free intradermal vaccine delivery for HPV.” Erin Spiegel, VP
Click here to view original post
News
Heska to Participate in the 41st J.P. Morgan Annual Healthcare Conference
LOVELAND, Colo., Dec. 23, 2022 /PRNewswire/ — Heska Corporation (NASDAQ: HSKA – News; “Heska” or the “Company”), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that members of Heska’s management team […]
News
nVoq Accelerates HIPAA-Compliant Clinical Documentation Across Multiple Devices with Addition of Mobile Voice for iOS
BOULDER, Colo., Aug. 20, 2024 /PRNewswire/ — nVoq Inc., the industry leader in transformative technology and AI-enabled voice-to-text solutions for in-home healthcare agencies, is proud to announce the expansion of its platform with the launch […]
News
Zynex Reports Fourth Quarter and Full Year 2024 Financial Results
ENGLEWOOD, Colo., March 11, 2025 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported […]
